Skip to content

Development of a Chinese Version of the New Geriatric Dehydration Screening Tool and Assessment of Its Reliability and Validity

Development of a Chinese Version of the New Geriatric Dehydration Screening Tool and Assessment of Its Reliability and Validity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101138
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration in elderly patients

Interventions

Trial group:None

Sponsors

The Third Affiliated Hospital of Nanjing Medical University (Changzhou Second People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years. 2. Gender: Both males and females are eligible. 3. Diagnostic Criteria for Diseases:Presence of dehydration-related symptoms (e.g., thirst, decreased urine output, reduced skin elasticity).Presence of chronic diseases (e.g., diabetes, chronic kidney disease, heart failure) or acute conditions (e.g., infection, fever) that pose a risk of dehydration. 4. Medical History and Disease Course:Clear history of dehydration-related conditions (e.g., recent vomiting, diarrhea, fever, excessive sweating).For patients with chronic diseases, the condition must be stable (disease duration >= 3 months).For patients with acute conditions, enrollment must occur within 72 hours of disease onset. 5. Medication Use:No recent use of medications that affect fluid balance (e.g., diuretics, fluid replacement therapy).If such medications are being used, the drug name and dosage must be recorded and stratified during analysis. 6. Normal Cognitive Function:Participants must have normal cognitive function to ensure they can understand and complete the screening process. 7. Informed Consent:Participants or their legal representatives must provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe Illness or Complications:Presence of severe diseases (e.g., advanced cancer, end-stage renal disease, severe liver failure).Presence of severe complications (e.g., shock, multiple organ failure). 2. Severe Cognitive Impairment:Inability to cooperate and complete the screening due to severe cognitive impairment. 3. Refusal to Provide Informed Consent:Participants or their legal representatives refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Structural validity;Content validity;Criterion validity;Test-retest reliability;

Countries

China

Contacts

Public ContactYan Yan

The Third Affiliated Hospital of Nanjing Medical University (Changzhou Second People's Hospital)

1258455412@qq.com+86 137 7563 0061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026